UPDATED INTERIM RESULTS OF AN INTERNATIONAL, MULTICENTER, PHASE 2 STUDY OF IBRUTINIB (PCI-32765) IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA Rule, S., Wang, M., Martin, P., Auer, R., Kahl, B., Jurczak, W., Advani, R., Romaguera, J., Williams, M., Barrientos, J., Chmielowska, E., Radford, J., Stilgenbauer, S., Troung, V., McGreivy, J., Clow, F., Beaupre, D., Kunkel, L., Goy, A., Blum, K. FERRATA STORTI FOUNDATION. 2013: 489

View details for Web of Science ID 000445782800210